Skip to Main Content

Advertisement

Skip Nav Destination

Phase II study of the novel oral Src-kinase inhibitor, AZD0530, in previously treated advanced colorectal cancer patients

Cancer Res (2008) 68 (9_Supplement): LB-76.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal